SCHEMBL1850403

SCHEMBL1850403

CCCCCCCCCCCc1noc(-c2ccc(CN(C(=O)C(=O)OCC)[C@H](C)c3ccc(C(F)(F)F)cc3)cc2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 8/20 0.42
PPARA Q07869 8/20 0.42
PPARD Q03181 4/20 0.42
SPHK1 Q9NYA1 3/20 0.41
SPHK2 Q9NRA0 3/20 0.36
S1PR1 P21453 1/20 0.36
S1PR5 Q9H228 1/20 0.36
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
HSP90AA1 P07900 1/20 0.35
MAPT P10636 1/20 0.35
CRHBP P24387 1/20 0.35
KMT2A Q03164 1/20 0.35
CRHR2 Q13324 1/20 0.35
ADORA2A P29274 1/20 0.34
ADORA2B P29275 1/20 0.34
ADORA1 P30542 1/20 0.34
CHRM2 P08172 2/20 0.34
CHRM4 P08173 2/20 0.34
CHRM5 P08912 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1852935 1.00 PPARG (0.42) PPARGPPARAPPARDSPHK1SPHK2
SCHEMBL1855614 1.00 PPARG (0.42) PPARGPPARAPPARDSPHK1SPHK2
SCHEMBL1855540 0.90 PPARG (0.44) PPARGPPARAPPARDSPHK1SPHK2
SCHEMBL1855288 0.90 PPARG (0.44) PPARGPPARAPPARDSPHK1SPHK2
SCHEMBL1854895 0.90 PPARG (0.44) PPARGPPARAPPARDSPHK1SPHK2
SCHEMBL6717446 0.89 PPARG (0.46) PPARGPPARAPPARDSPHK1SPHK2
SCHEMBL6717440 0.89 PPARG (0.46) PPARGPPARAPPARDSPHK1SPHK2
SCHEMBL1854957 0.88 SPHK1 (0.45) PPARGPPARAPPARDSPHK1SPHK2
SCHEMBL1853726 0.88 SPHK1 (0.45) PPARGPPARAPPARDSPHK1SPHK2
SCHEMBL1854905 0.88 SPHK1 (0.43) PPARGPPARAPPARDSPHK1SPHK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1470102-B1 SUBSTITUTED METHYLENE AMIDE DERIVATIVES AS MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPS) MERCK SERONO SA (CH) 2011-05-25 EP disclosed
US-7592477-B2 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (PTPs) LABORATOIRES SERONO SA (CH) 2009-09-22 US disclosed
US-20050124656-A1 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps) APPLIED RESEARCH SYSTEMS ARS (NL) 2005-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124656-A1 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps) PTPRS, PTPA, PTPMT1 PPARG 461/4885PPARA 579/4885PPARD 695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.